GWAS Pinpoints Gene Linked to Decreased Alcohol Cirrhosis Risk
Complete the form below to unlock access to ALL audio articles.
Researchers at Indiana University School of Medicine are learning more about how a person’s genes play a role in the possibility they’ll suffer from alcoholic cirrhosis with the discovery of a gene that could make the disease less likely.
Alcoholic cirrhosis can happen after years of drinking too much alcohol. According to the researchers, discovering more about this illness couldn’t come at a more important time.
The team describes their findings in a new paper published in Hepatology. The GenomALC Consortium was funded by the National Institutes on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institute of Health (NIH). This genome-wide association study began several years ago and is one of the largest studies related to alcoholic cirrhosis ever performed. DNA samples were taken from over 1,700 patients from sites in the United States, several countries in Europe and Australia and sent to IU School of Medicine where the team performed the DNA isolation for genome analysis. The patients were divided into two groups—one made up of heavy drinkers that never had a history of alcohol-induced liver injury or liver disease and a second group of heavy drinkers who did have alcoholic cirrhosis.
“Our key finding is a gene called Fas Associated Factor Family Member 2, or FAF2,” said Tae-Hwi Schwantes-An, PhD, assistant research professor of medical and molecular genetics and the lead author of the study. “There’s this convergence of findings now that are pointing to the genes involved in lipid droplet organization pathway, and that seems to be one of the biological reasonings of why certain people get liver disease and why certain people do not.”
“We know for a fact those genes are linked together in a biological process, so the logical next step is to study how the changes in these genes alter the function of that process, whether it’s less efficient in one group of people, or maybe it’s inhibited in some way,” Schwantes-An said. “We don’t know exactly what the biological underpinning of that is, but now we have a pretty well-defined target where we can look at these variants and see how they relate to alcoholic cirrhosis.”
As their research continues, the team hopes to eventually find a way to identify this genetic factor in patients with the goal of helping them prevent alcoholic cirrhosis in the future or developing targeted therapies that can help individuals in a more personalized way.
Liangpunsakul is also an associate chief of staff for research at the Richard L. Roudebush Veterans Administration Medical Center in Indianapolis. Tatiana Foroud, PhD, executive associate dean for research affairs for IU School of Medicine, is another senior author of the study. Timothy Morgan, MD, professor of medicine at the University of California-Irvine and chief of hepatology at the Veterans Administration Long Beach, and Devanshi Seth, MD, clinical associate professor at the University of Sydney, Australia are also co-principal investigators of this project.
Reference: Schwantes-An T-H, Darlay R, Mathurin P, et al. Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors. Hepatology. 2020;n/a(n/a). doi:10.1002/hep.31535.
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.